Epitranscriptomic regulation of HIF-1: bidirectional regulatory pathways

Area of Science:

• Molecular Biology
• Epigenetics
• Cellular Biology

Background:

• Epitranscriptomics studies RNA modifications, such as N⁶-methyladenosine (m⁶A), revealing a new layer of gene regulation.
• Hypoxia-inducible factor-1 (HIF-1) is a key regulator of cellular responses to low oxygen, impacting cancer and ischemic heart disease.
• Emerging evidence points to a dynamic, bidirectional relationship between m⁶A modifications and HIF-1 signaling.

Purpose of the Study:

• To review the reciprocal regulation between HIF-1 and epitranscriptomic machinery.
• To explore the implications of this interplay for cellular hypoxic responses.
• To highlight potential clinical applications in treating hypoxia-related conditions.

Main Methods:

• Review of existing literature on HIF-1 and m⁶A interactions.
• Analysis of how HIF-1 modulates m⁶A components (writers, readers, erasers).
• Examination of how m⁶A modifications regulate HIF-1 mRNA.

Main Results:

• HIF-1 influences the expression of m⁶A machinery components.
• HIF-1 mRNA itself is subject to m⁶A-mediated regulation.
• Selective inhibitors targeting the m⁶A-HIF-1 axis show promise but face challenges.

Conclusions:

• The m⁶A-HIF-1 axis is crucial for hypoxia-driven processes.
• Further research can unlock therapeutic innovations for cancer and ischemic heart disease.
• Overcoming challenges in specificity and off-target effects is key for clinical translation.